Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Terminated 3Recruiting 2Unknown 1Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 96Lung Neoplasms 38Neoplasms 10Mesothelioma, Malignant 9Mesothelioma 8Adenocarcinoma of Lung 8Small Cell Lung Carcinoma 7Neoplasm Metastasis 7Thoracic Neoplasms 5Recurrence 5Lung Diseases 5Carcinoma 5Respiratory Tract Neoplasms 4Carcinoma, Bronchogenic 4Brain Neoplasms 4Respiratory Tract Diseases 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Neoplasms by Site 3Neoplasms by Histologic Type 3NSCLC 3Head and Neck Neoplasms 3Bronchial Neoplasms 3Adenocarcinoma, Bronchiolo-Alveolar 3Adenocarcinoma 3Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Non-small-cell Lung Cancer With Somatic EGFR Mutations 2Neoplasms, Nerve Tissue 2Melanoma 2

Interventions

Pemetrexed 3Carboplatin 3osimertinib 2patritumab 1napabucasin 1atezolizumab 1alectinib 1Technetium Tc 99m Aggregated Albumin 1Patient Reported Outcome Measures 1Paclitaxel 1Erlotinib Hydrochloride 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Bronchial Neoplasms × Pemetrexed × Clear all
NCT04512430 2025-04-02

Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients

Fundación GECP

Phase 2 Terminated
4 enrolled 9 charts
Thoracic

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT05241873 2025-02-10

(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations

Blueprint Medicines Corporation

Phase 1 Terminated
103 enrolled
CNSThoracic

Adenocarcinoma, Brain Neoplasms, Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT05153408 2023-06-18

(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC

Blueprint Medicines Corporation

Phase 1 Terminated
20 enrolled
Thoracic

Adenocarcinoma, Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Nerve Tissue, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡